Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide (FHIR R4), published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health-ips/ and changes regularly. See the Directory of published versions

Example Bundle: Renee Gravitate's IPS

id: gravitate-Renee
Composition status: final
Composition Type: Patient summary Document
Subject:
identifier: Renee-1
Name: Renee Gravitate
active: true
gender: female
Birth Date: 1950-10-05

Sections

Problem List

Condition: Aortic valve stenosis (60573004)
clinicalStatus: active
Condition: Heart failure (84114007)
clinicalStatus: active
asserter: Dr. Walter Waltz
onsetDateTime: 2018

Medication Summary

Medication: aspirin 75 mg
status: active
Medication Detail:
  • System https://www.gravitatehealth.eu/sid/doc Code: himss-Aspirin [Aspirin 75 mg]
Dose Form: Tablet
Ingredient: HYPERICUM PERFORATUM WHOLE (http://fdasis.nlm.nih.gov#XK4IUX8MNB)
strength: 75 mg/1 Tablet
Route: Oral use
Medication: Atorvastatin 40 mg PO nightly
status: active
Medication Detail:
  • System https://www.gravitatehealth.eu/sid/doc Code: himss-Atorvastatin [Atorvastatin 40 mg]
Dose Form: Tablet
Ingredient: Calcium carbonate (http://fdasis.nlm.nih.gov#H0G9379FGK)
strength: 40 mg/1 Tablet
Route: Oral use
Medication: Furosemide 20 mg PO AM (↑ PRN)
status: active
Medication Detail:
  • System https://www.gravitatehealth.eu/sid/doc Code: himss-Furosemide [Furosemide 20 mg]
  • System https://spor.ema.europa.eu/pmswi Code: himss-3 [Furosemide 20 mg PO AM (↑ PRN)]
Dose Form: Tablet
Ingredient: HYPERICUM PERFORATUM WHOLE (http://fdasis.nlm.nih.gov#XK4IUX8MNB)
strength: 20 mg/1 Tablet
Route: Oral use
Medication: Ramipril 1.25 mg PO nightly (titrate q1-2 wk)
status: active
Medication Detail:
  • System https://www.gravitatehealth.eu/sid/doc Code: himss-ramipril [Ramipril 1.25 mg]
Dose Form: Tablet
Ingredient: INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) WHOLE (http://fdasis.nlm.nih.gov#TU2UN5CG9C)
strength: 1.25 mg/1 Tablet
Route: Oral use
Medication: Loratadine
status: active
Medication Detail:
  • System https://www.gravitatehealth.eu/sid/doc Code: himss-loratadine [Loratadine 10 mg]
Dose Form: Tablet
Ingredient: INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) WHOLE (http://fdasis.nlm.nih.gov#TU2UN5CG9C)
strength: 10 mg/1 Tablet
Route: Oral use